Skip to search formSkip to main contentSkip to account menu

AT-2266

Known as: AT 2266, AT2266 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The pharmacokinetis of AT-2266 (1-ethyl-luoro-1,4-dihydro-4oxo-7-(1-pi- perazinyl)1,8-naprhthyridine-3-caboxylic acid) were… 
1986
1986
From August of 1982 through February of 1983, the Sapporo Clinical Research Group for STD treated 131 cases of male gonorrheal… 
1986
1986
AT-2266 tablets were administered orally in a daily dosage of 600 mg for 7 consecutive days as treatment of non-gonorrheal… 
1985
1985
Enoxacin (CI-919; AT-2266), a new naphthyridine derivative was found to induce morphologic changes at very low concentrations in…